Tag: Pancreatic cancer

Simon Turcotte

Assistant professor, Department of Surgery, Université de Montréal Hepato-pancreato-biliary (HPB) Surgeon, Centre hospitalier de l’Université de Montréal (CHUM) Scientist, CHUM Research Center Cancer Axis (CRCHUM) Roger Des Groseillers Research Chair in HPB Surgical Oncology Director, CHUM HPB Cancer Biobank & Clinical Database Co-lead, CHUM adoptive T cell immunotherapy program   Full Biography   Cancers of… Read more »

Sachdev Sidhu

Professor, Donnelly Centre, University of Toronto Senior Investigator, Ontario Institute for Cancer Research (OICR)   Full Biography   Cancers of Interest Bladder, Blood, Brain, Breast, Colorectal, Gastric, Head and Neck, Kidney, Liver, Lung, Neuroblastoma, Ovarian, Pancreatic, Prostate, Skin   Research and clinical approaches The Sidhu lab studies the relationships between protein structure and function, using… Read more »

Brad Nelson

Scientist & Director, Deeley Research Centre Co-Director, Immunotherapy Program, BC Cancer Agency   Full Biography   Projects at BioCanRx Adoptive T cell therapy targeting patient-specific driver mutations in lymphoma   Introducing the winners of BioCanRx’s 2019 Summer Studentships   Summit4CI 2018: The HQP Experience   Meet Two of BioCanRx’s Summer Students   Removing obstacles to… Read more »

Steven Jones

Co-Director, Michael Smith Genome Sciences Centre, BC Cancer Agency Professor, Molecular Biology & Biochemistry, Simon Fraser University Professor, Medical Genetics, University of British Columbia   Full Biography   Cancers of Interest Bladder, Blood, Bone, Brain, Breast, Cervical, Colorectal, Endometrial, Esophageal, Gastric, Gastrointestinal stromal tumours (GIST), Genitourinary, Gynecologic, Head and neck, Kidney, Liver, Lung, Neuroblastoma, Ovarian,… Read more »

Naoto Hirano

Senior Scientist, Princess Margaret Cancer Centre   Full Biography   Cancers of Interest Blood, Breast, Lung, Ovarian, Pancreatic, Prostate, Skin, Soft Tissue Sarcoma   Research Interests and Clinical Approach Dr. Hirano’s research team is particularly interested in understanding how the interactions between T cells and antigen-presenting cells affect priming, expansion, persistence and differentiation of T… Read more »

Jean-Simon Diallo

Scientist, Ottawa Hospital Research Institute Assistant Professor, University of Ottawa, BMI Department   Full Biography   Cancers of Interest Sarcoma Prostate Breast   Research Interests and Clinical Approach Oncolytic Virotherapy Viral sensitizers Combination Immunotherapy   Projects at BioCanRx Scalable Vector Manufacturing Enhancement Using Viral Sensitizers   BioCanRX and Partners Announce Funding for Eight New Projects… Read more »

Marcus Butler

Medical Oncologist, Princess Margaret Cancer Centre   Full Biography   Cancers of Interest Bladder Cervical Esophageal Gastric Gynecologic Ovarian Pancreatic Skin   Research Interests and Clinical Approach Clinical trials research focuses on adoptive immunotherapy for multiple different solid tumor types   Projects and Articles at BioCanRx   Phase Ib trial of pembrolizumab administered following adoptive… Read more »

Rebecca Auer

MD, MSc, FRCSC   Full Biography   Cancers of Interest Peritoneal solid tumors   Research Interests and Clinical Approach Perioperative immunotherapy ICV immunotherapy   Projects at BioCanRx Optimizing a personalized infected cell vaccine (ICV) for peritoneal carcinomatosis   Dr. Rebecca Auer receives grant from Canadian Cancer Society   Introducing the winners of BioCanRx’s 2019 Summer… Read more »

Pancreatic cancer loses viral defences when talking with supporting cells

Media release   Ottawa researchers have unlocked a way to make pancreatic cancer cells more vulnerable to cancer-killing viruses, known as oncolytic viruses. Outlined in a paper published today by Nature Medicine, the scientists have discovered how they can exploit the communication, or cross-talk, between pancreatic cancer and a specific cell type that supports the… Read more »